tradingkey.logo

Treace Medical Concepts Inc

TMCI
View Detailed Chart
2.260USD
+0.220+10.78%
Close 02/06, 16:00ETQuotes delayed by 15 min
143.97MMarket Cap
LossP/E TTM

Treace Medical Concepts Inc

2.260
+0.220+10.78%
Intraday
1m
30m
1h
D
W
M
D

Today

+10.78%

5 Days

-2.59%

1 Month

-22.60%

6 Months

-58.68%

Year to Date

-7.76%

1 Year

-78.02%

View Detailed Chart

Key Insights

Treace Medical Concepts Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 120 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 4.84.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Treace Medical Concepts Inc's Score

Industry at a Glance

Industry Ranking
120 / 205
Overall Ranking
315 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Treace Medical Concepts Inc Highlights

StrengthsRisks
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 47.60% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 209.36M.
Overvalued
The company’s latest PE is -2.85, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 38.84M shares, decreasing 28.68% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 4.87K shares of this stock.

Analyst Rating

Based on 6 analysts
Hold
Current Rating
4.838
Target Price
+137.13%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Treace Medical Concepts Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Treace Medical Concepts Inc Info

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Ticker SymbolTMCI
CompanyTreace Medical Concepts Inc
CEOTreace (John T)
Websitehttps://www.treace.com/
KeyAI